| Literature DB >> 28069965 |
Marc-André Lécuyer1, Olivia Saint-Laurent1, Lyne Bourbonnière1, Sandra Larouche1, Catherine Larochelle1, Laure Michel1, Marc Charabati1, Michael Abadier2, Stephanie Zandee1, Neda Haghayegh Jahromi2, Elizabeth Gowing1, Camille Pittet1, Ruth Lyck2, Britta Engelhardt2, Alexandre Prat3,4.
Abstract
Activated leukocyte cell adhesion molecule (ALCAM) is a cell adhesion molecule found on blood-brain barrier endothelial cells (BBB-ECs) that was previously shown to be involved in leukocyte transmigration across the endothelium. In the present study, we found that ALCAM knockout (KO) mice developed a more severe myelin oligodendrocyte glycoprotein (MOG)35-55-induced experimental autoimmune encephalomyelitis (EAE). The exacerbated disease was associated with a significant increase in the number of CNS-infiltrating proinflammatory leukocytes compared with WT controls. Passive EAE transfer experiments suggested that the pathophysiology observed in active EAE was linked to the absence of ALCAM on BBB-ECs. In addition, phenotypic characterization of unimmunized ALCAM KO mice revealed a reduced expression of BBB junctional proteins. Further in vivo, in vitro, and molecular analysis confirmed that ALCAM is associated with tight junction molecule assembly at the BBB, explaining the increased permeability of CNS blood vessels in ALCAM KO animals. Collectively, our data point to a biologically important function of ALCAM in maintaining BBB integrity.Entities:
Keywords: ALCAM; EAE; blood–brain barrier; multiple sclerosis; tight junctions
Mesh:
Substances:
Year: 2017 PMID: 28069965 PMCID: PMC5278491 DOI: 10.1073/pnas.1614336114
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205